ArticleVaccines2022
Knowledge and Awareness of Algerian Students about Cervical Cancer, HPV and HPV Vaccines: A Cross-Sectional Study.
Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.Human vaccines & immunotherapeutics · 2026Pooled it
- Awareness and Knowledge Levels of Cervical Cancer and HPV and Attitudes Toward HPV Vaccination in Algeria.Vaccines · 2026Article
- Advancing the elimination of cervical cancer across Africa.Nature communications · 2026Review
- Article
- Cancer Screening and Prevention in MENA and Mediterranean Populations: A Multi-Level Analysis of Barriers, Knowledge Gaps, and Interventions Across Indigenous and Diaspora Communities.Diseases (Basel, Switzerland) · 2025Review
- Initial Coverage and Regional Disparities of the National HPV Vaccination Program in Poland: A Cross-Sectional Analysis.Healthcare (Basel, Switzerland) · 2025Article
- Knowledge of human papillomavirus and self-sampling, including vaccination practices among female students in Free State, South Africa.Cancer causes & control : CCC · 2025Article
- Article
- New Vaccine Introduction in Middle-Income Countries Across the Middle East and North Africa-Progress and Challenges.Vaccines · 2025Review
- Knowledge and attitudes of medical students regarding human papilloma virus infection and vaccine: cross-sectional study from Jordan.Frontiers in cellular and infection microbiology · 2025Article
- Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State.Journal of family medicine and primary care · 2025Article
- Assessment of knowledge and attitudes toward human papillomavirus and its vaccination among female nursing students at Umm Al-Qura University, Saudi Arabia.Frontiers in global women's health · 2025Article
- Review
- Information-seeking Behavior of Iranian Young Adults (18-28 Years Old) Regarding HPV on Social Media: A Preventive Approach to HPV.International journal of preventive medicine · 2024Article
- Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs.Human vaccines & immunotherapeutics · 2023Article
- First Year of Special Issue "New Insights in Vaccination and Public Health": Opinions and Considerations.Vaccines · 2023Article
- Awareness of Human Papillomavirus among Male and Female University Students in Saudi Arabia.Healthcare (Basel, Switzerland) · 2023Article
- HPV Vaccine Knowledge and Hesitancy Among Health Colleges' Students at a Saudi University.Journal of multidisciplinary healthcare · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is one of the most recurrent and dangerous female cancers in Algeria and worldwide. It is mainly caused by human papillomaviruses (HPV), which can induce other cancers as well. Although it can be fatal, cervical cancer is one of the most preventable and manageable cancers. While HPV vaccination is the key weapon to win the battle against this pathology, it is still not approved in Algeria. Therefore, we set up a cross-sectional survey to assess the knowledge and awareness of students from Algerian universities concerning cervical cancer and HPV and to understand their attitudes towards HPV vaccination. The results reveal that, out of 715 students, the majority of students were aware of cervical cancer (84.6%). However, only 46.2% of students had heard about HPV. Furthermore, willingness to get the HPV vaccine was estimated at 26.7% among students with prior knowledge of HPV, and 21.5% of these students claimed to be willing to pay to get the HPV vaccine if available. Nevertheless, HPV vaccine hesitancy was estimated at 37.5% among the students aware of HPV. The main causes of HPV vaccine reluctance were: complacency (30.6%), refusal of vaccination in general (20.2%) and belief in the rarity of HPV-induced infections in Algeria (19.4%). Moreover, the embrace of vaccine conspiracy beliefs among students were significantly related with their HPV vaccine rejection. Overall, these findings encourage the establishment of a social education policy concerning the fight against HPV-induced cancers, particularly that of the cervix, and the implementation of a national HPV vaccination program targeting young people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.